Major GRDN holder Bindley entity sells 3.57M Guardian Pharmacy shares

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. director and 10% owner William E. Bindley reported an indirect open‑market sale of 3,570,677 shares of Class A common stock at an average price of $29.6825 per share. The shares were held by Bindley Capital Partners I, LLC and were sold pursuant to an underwriting agreement with BofA Securities, Inc. and Jefferies LLC. Following this secondary sale, Bindley Capital Partners I, LLC continues to hold 4,469,316 shares of Class A common stock indirectly associated with Bindley.

Insights

Equity markets analyst

Large secondary sale by major holder, but substantial stake remains.

The filing shows Bindley Capital Partners I, LLC, associated with director and 10% owner William E. Bindley, completed an underwritten secondary sale of 3,570,677 Class A shares at $29.6825 per share. This is a sizable liquidity event executed through investment banks BofA Securities and Jefferies.

After the transaction, the entity still holds 4,469,316 Class A shares, so Bindley retains a significant indirect ownership position. Because this is a secondary sale by an existing holder rather than a new issuance, it does not change the company’s share count; market impact depends on how investors absorb the additional trading float.

Insider Trade Summary

Net Seller: 3,570,677 shares ($105,986,620)

Net Sell 1 txn

Insider BINDLEY WILLIAM E

Role Director, 10% Owner

Sold 3,570,677 shs ($105.99M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	3,570,677	$29.6825	$105.99M

Holdings After Transaction: Class A Common Stock — 4,469,316 shares (Indirect, By Bindley Capital Partners I, LLC)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BINDLEY WILLIAM E

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		S(1)		3,570,677	D	$29.6825	4,469,316	I	By Bindley Capital Partners I, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

	/s/ Douglas Towns, Attorney-in-Fact	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Guardian Pharmacy Services (GRDN) disclose?

Guardian Pharmacy Services disclosed that an entity associated with director and 10% owner William E. Bindley sold 3,570,677 Class A common shares. The sale was executed in the open market as part of an underwritten offering arranged with BofA Securities and Jefferies.

Who executed the share sale related to William E. Bindley at GRDN?

The sale was executed by Bindley Capital Partners I, LLC, an entity associated with director and 10% owner William E. Bindley. The filing classifies the ownership as indirect and describes the transaction as an open‑market sale under an underwriting agreement.

How many Guardian Pharmacy Services shares were sold and at what price?

The insider filing reports a sale of 3,570,677 shares of Guardian Pharmacy Services Class A common stock at an average price of $29.6825 per share. This represents a large secondary block sold into the market through underwriters.

How many GRDN shares does the Bindley‑related entity hold after the sale?

After the reported transaction, Bindley Capital Partners I, LLC holds 4,469,316 shares of Guardian Pharmacy Services Class A common stock. These shares are reported as indirectly owned by director and 10% owner William E. Bindley in the Form 4 filing.

Was the Guardian Pharmacy Services insider sale part of an underwriting agreement?

Yes. The footnote explains the Class A common shares were sold under an underwriting agreement dated March 18, 2026, among Guardian Pharmacy Services, the selling stockholders, and underwriters led by BofA Securities, Inc. and Jefferies LLC as representatives.